Clinical trial Recruiting at 1 site Interventional Ages 65 to 100

Comparing three motor-sparing nerve blocks for pain after hip replacement

Official title: A Randomized, Double-Blinded, Controlled Trial Comparing the Analgesic Efficacy and Motor-Sparing Properties of the Pericapsular Nerve Group (PENG) Block, Suprainguinal Fascia Iliaca Compartment Block (S-FICB), and Lumbar Erector Spinae Plane Block (L-ESPB) in Patients Undergoing Hip Arthroplasty

Run by Poznan University of Medical Sciences · NCT07288983 · Data updated 2026-11-12

This trial will test whether the PENG block, suprainguinal FICB, or lumbar ESPB provides the best pain relief while preserving leg strength after hip arthroplasty in adults 65 and older.

Quick facts

Study typeInterventional
Ages65 Years to 100 Years
SexAll
Enrollment93 (estimated)
SponsorPoznan University of Medical Sciences
Academic / other
Locations1 site (Poznan)
StatusRecruiting
StartedFebruary 6, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 31, 2027
Registry record updatedMarch 4, 2026
Trial IDNCT07288983 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 65 years or older scheduled for elective hip arthroplasty under spinal anesthesia who can give informed consent, reliably use a numeric pain scale, meet ASA II-III criteria, and are expected to remain hospitalized for at least 48 hours.

Probably not a fit

Patients with coagulopathy or therapeutic anticoagulation, local infection at the block site, allergy to local anesthetics, pre-existing lower-limb neurological deficits, severe spinal deformity, chronic opioid dependence, or inability to consent or report pain are unlikely to be eligible or to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blinded, three-arm controlled study enrolls adults aged 65 and older undergoing elective hip arthroplasty under spinal anesthesia and randomizes them to receive a PENG block, suprainguinal FICB, or lumbar ESPB for postoperative analgesia. Investigators will compare postoperative pain scores at rest and during movement, opioid consumption, time to first rescue analgesia, quadriceps strength, incidence of nausea and vomiting, block-related adverse events, and early mobilization. Blocks are selected for their motor-sparing potential to facilitate early mobilization, and outcome data will be collected during at least 48 hours of postoperative hospitalization. The trial aims to determine which technique best balances effective analgesia with preserved motor function to improve early functional recovery after hip surgery.

Why it matters

Potential benefit: If successful, the trial could identify a nerve-block technique that reduces postoperative pain and opioid use while preserving quadriceps strength and enabling earlier, safer mobilization.

How similar studies have gone: Smaller randomized trials and observational studies indicate that PENG, suprainguinal FICB, and ESPB can reduce postoperative pain and opioid use, but direct head-to-head randomized comparisons of all three techniques in the same population are limited, so this comprehensive comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 65 years or older scheduled to undergo elective hip arthroplasty under spinal anesthesia.
* Ability to provide written informed consent.
* Ability to understand and reliably use numerical pain assessment tools (NRS 0-10).
* ASA physical status II-III.
* Expected postoperative hospitalization of at least 48 hours to ensure complete data collection.

Exclusion Criteria:

* Inability to provide informed consent due to cognitive impairment, language barrier, or severe hearing/speech limitations.
* Coagulopathy or therapeutic anticoagulation not meeting safety criteria for regional anesthesia.
* Local infection at the planned block site.
* Allergy, hypersensitivity, or contraindication to ropivacaine, local anesthetics, or study medications.
* Pre-existing lower-limb neurological deficits (motor or sensory) affecting outcome assessments.
* Severe spinal deformity or anatomical limitations preventing safe performance of regional blocks.
* Chronic opioid use (defined as \>30 mg oral morphine equivalents daily for more than 2 weeks).
* Severe renal failure (eGFR \<30 mL/min/1.73m²) or severe hepatic impairment.
* Uncontrolled diabetes mellitus (fasting glucose \>300 mg/dL or HbA1c \>10%).
* History of local anesthetic systemic toxicity (LAST).
* Participation in another interventional clinical trial within the past 30 days.
* Any condition deemed by investigators to interfere with protocol adherence, safety monitoring, or outcome reliability.

Where it's running

  • Poznan University of Medical Sciences
    Poznan, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.